Shivam Singh

Dr. Shivam Singh

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2025 in Microchimica Acta
Verified
Journal Article
Closed access
PDF file
HBhiba bouandas
hiba bouandas
RKRajeev Kumar
Rajeev Kumar
MBMostefa Benhaliliba
Mostefa Benhaliliba
SSShivam Singh
Shivam Singh
LGLalit Garia
Lalit Garia


15 April 2024 in IEEE Transactions on Plasma Science
Verified
Journal Article
Closed access
RKRajeev Kumar
Rajeev Kumar
SSShivam Singh
Shivam Singh
BCBhargavi Chaudhary
Bhargavi Chaudhary
Santosh KumarSantosh Kumar
Santosh Kumar
In this work, we proposed and performed the numerical analysis of novel surface plasmon resonance (SPR) biosensor architecture (Prism-BAK1/Ag/WS $_{2}$ /Ni/BP/SM) based on angular interrogation at a wavelength of 633 nm. At minimum reflectance ( $R_{\mathrm{min}})$ value, the remarkable sensitivity and figure of merit (FoM) of 198.15 $^{\circ}$ /RIU and 64.79/RIU are attained at a refractive index (RI) range of 1.33–1.41 for the sensing medium (SM). Additionally, the performance parameters of the SPR biosensor are meticulously measured in relation to FoM, sensitivity, limit of detection (LoD), and detection accuracy (DA) concerning the concentration of complementary target DNA hybridization in the SM. The maximum sensitivity is achieved with DNA hybridization. Notably, the probe and mismatch DNA hybridization demonstrate the maximum sensitivities of 379.69 $^{\circ}$ /RIU and 383.01 $^{\circ}$ /RIU, respectively. Thus, this structure-based SPR biosensor can distinguish between single nucleotide polymorphism (SNP) and DNA hybridization. In the realm of biomedicine, this adaptable biosensor holds great potential for the detection of life-threatening diseases through DNA hybridization.

3 January 2023 in IEEE Transactions on Nanobioscience
Verified
Journal Article
Closed access
SSShivam Singh
Shivam Singh
YPYogendra Kumar Kumar Prajapati
Yogendra Kumar Kumar Prajapati
This work presents a single-core bowl-shaped bottom-side polished (BSP) photonic crystal fiber (PCF) sensor based on surface plasmon resonance (SPR) concept for the early detection of hazardous cancer cells in human blood, skin, cervical, breast, and adrenal glands. We have studied liquid samples of cancer-affected and healthy samples with their concentrations/refractive indices in the sensing medium. To induce a plasmonic effect in the PCF sensor, the bottom flat section of a silica PCF fiber is coated with a 40nm plasmonic material, such as gold. To strengthen this effect, a thin TiO 2 layer of 5 nm is sandwiched between fiber and gold as it strongly holds gold nanoparticles with smooth fiber surface. When the cancer-affected sample is introduced to the sensor’s sensing medium, it produces a different absorption peak in the form of a resonance wavelength than the healthy sample. This reallocation of the absorption peak is used to determine sensitivity. Hence, the obtained sensitivities for blood cancer, cervical cancer, adrenal gland cancer, skin cancer, and breast cancer (type-1and type-2) cells are 22,857nm/RIU, 20000nm/RIU, 20714nm/RIU, 20000nm/RIU, 21428nm/RIU, and 25000, respectively, with highest detection limit 0.024. These strong findings indicate that our proposed cancer sensor PCF is a viable choice for early cancer cell detection.

23 November 2023 in IEEE Sensors Journal
Verified
Journal Article
Closed access
SSShivam Singh
Shivam Singh
AUAnurag Upadhyay
Anurag Upadhyay
BCBhargavi Chaudhary
Bhargavi Chaudhary
KSKapil Sirohi
Kapil Sirohi
Santosh KumarSantosh Kumar
Santosh Kumar
In this work, a bimetallic (Cu-Ni) prism-based surface plasmon resonance (SPR) sensor is presented. To enhance the interaction of bio-analytes with sensing surface, a 2-D nanomaterial black phosphorous (BP) is used as it exhibits high biomolecule adsorption on its surface. Our investigation includes an assessment of key performance parameters such as sensitivity (S), full width at half maximum (FWHM), detection accuracy (DA), figure of merit (FoM), and penetration depth (PD). We meticulously optimized the thicknesses of the Copper, Nickel, and TiO 2 layers to achieve optimal sensor performance. Our findings demonstrate that the highest sensitivity (S) is achieved with a configuration comprising a 25 nm layer of Cu, a 20 nm layer of Ni, a 1 nm layer of TiO 2 , and a monolayer of BP, resulting in a remarkable sensitivity (S) of 516°/RIU, with remarkable DA, FWHM and FoM of 0.20/°, 6.15° and 83.59/RIU, respectively. The incorporation of the TiO 2 layer between the Ni and BP layers contributes to the enhanced sensitivity. Additionally, our proposed sensor configuration is well-suited for the detection of biomolecules within the refractive index (RI) range of 1.330-1.335. We further assessed the sensor’s capabilities in detecting the SARS-CoV-2 coronavirus, which exhibits RI values falling within the considered range (1.3348 and 1.3398). After optimizing the thickness of the metal layers, our sensor achieves an optimal sensitivity of 502°/RIU for SARS-CoV-2 virus detection. This configuration also maintains excellent DA, FWHM, and FoM values of 0.20/°, 4.9°, and 100.56/RIU, respectively.

15 April 2024 in IEEE Sensors Journal
Verified
Journal Article
Closed access
SSShivam Singh
Shivam Singh
BCBhargavi Chaudhary
Bhargavi Chaudhary
RKRajeev Kumar
Rajeev Kumar
AUAnurag Upadhyay
Anurag Upadhyay
Santosh KumarSantosh Kumar
Santosh Kumar
In this work, a surface plasmon resonance (SPR) plasmonic photonic crystal fiber (PCF) biosensor embedded with a rectangular open channel (ROC) is proposed, enabling precise detection and discrimination between healthy and tumorous brain tissues. Healthy and tumorous tissues are considered liquid tissues, each possessing its own distinctive refractive index (RI). The ROC is coated with gold (Au) to generate surface plasmons. To facilitate ample biomolecules, a thin Ti 3 C 2 Tx-MXene layer is functionalized over gold. A thin TiO 2 layer is coated on the ROC surface to strongly hold the Au nanoparticles, ensuring improved sensing performance. Healthy, cancerous, and tumor tissue samples exhibit unique resonance wavelengths, allowing for their diagnosis through the measurement of shifts in their respective resonance wavelengths. The essential performance parameters, including sensitivity (S), full width at half maximum (FWHM), and figure of merit (FoM) are evaluated. The computed sensitivities for normal and abnormal tissues i.e ., gray matter, cerebrospinal fluid and oligodendroglioma are 12352.94 nm/RIU, 2030.45 nm/RIU, and 672.26 nm/RIU, measured with respect to white matter and the wall of a solid brain. And, for tumorous tissues (cancers and tumors) such as glioblastoma, lymphoma and metastasis, the sensitivities are 800 nm/RIU, 774.9 nm/RIU, and 643.26 nm/RIU, measured with respect to low grade glioma (Benign). Additionally, the proposed biosensor’s resolution (R) ranges from 1.25 × 10 -4 to 8.09 × 10 -6 RIU along with the maximum FoM of 126.05 RIU -1 . Hence, this biosensor is poised to excel in the detection of tumor and cancer tissues, making it a promising candidate for advancing medical diagnostics.